Marijuana Stocks & Publicly Traded Cannabis Companies

Provincial Preview: Quebec cannabis market isn’t the entrepreneurial wasteland you might think it is

Quebec’s nascent marijuana industry may be home to a disproportionately small number of licensed producers and off-limits to entrepreneurs in the retail sector, but that doesn’t mean the province lacks opportunity.

You just need to know where to look, particularly among cannabis-related ancillary businesses.

The province’s medical market, for one, has nowhere to go but up.

Read More

Demand for medical marijuana is surging in Germany

Demand for medical marijuana in Germany is surging, opening new opportunities for overseas companies. Canadian MMJ companies, in particular, have been quick to position themselves to meet a supply shortfall in Germany. By the end of 2017, a total of 13,000 patients had applied for medical marijuana reimbursements from three large health insurance companies, Rheinische Post reported. […]

Read More

Deal will allow CanniMed to distribute medical marijuana in 17 countries  

A major Canadian licensed producer has sealed an arrangement with a Dutch pharmaceutical distributor to market and sell its medical marijuana products in 17 countries. Saskatchewan-headquartered CanniMed Therapeutics, traded on the Toronto Stock Exchange as CMED, entered into a global marketing and distribution agreement with Fagron NV of the Netherlands. Financial terms were not disclosed. Under […]

Read More

Canadian marijuana producers have bankrolled more than enough capacity to meet rec demand

If a recreational marijuana shortage materializes in Canada come 2019 – as most industry observers predict – don’t blame Health Canada, which more than doubled the number of production licenses it granted in 2017.

Instead, look to regional supply imbalances – possibly in provinces that opt to sell adult-use cannabis through government-run retail outlets – and producers who fail to live up to their cultivation targets.

Read More

Canadian medical cannabis company inks deal to supply German pharmacies

A Canadian medical marijuana company secured a deal with Germany’s CC Pharma GmbH to export MMJ products for distribution through thousands of German pharmacies. Nuuvera Inc. – which has a strategic partnership with Aphria (TSE: APH) to build a 1-million-square-foot greenhouse – will supply approximately 1,200 kilograms of medical cannabis to CC Pharma, which distributes pharmaceuticals to over […]

Read More

Saskatchewan gives cannabis rec sales and wholesale to private sector

Saskatchewan’s adult-use marijuana will be sold in private brick-and-mortar stores and online, the government announced, giving entrepreneurs in the cannabis space more opportunities when sales begin this summer. Saskatchewan is the last Canadian province to announce plans for marijuana sales. However, major decisions on home cultivation, taxation, a minimum age for cannabis consumption and public-use […]

Read More

Canadian cannabis companies with US operations must disclose risks

An exchange in Canada dominated by marijuana stocks has asked listed companies with U.S. operations to publicly detail any risks they face after Attorney General Jeff Sessions’ decision to scrap protections for state-legal cannabis businesses. Richard Carleton, chief executive officer of the Canadian Securities Exchange, told Marijuana Business Daily that the exchange contacted all CSE-listed companies with […]

Read More

Chart: Marijuana stocks stumble, then rebound after Sessions announcement

Marijuana stock investors are wagering that Jeff Sessions’ bark will be bigger than his bite. U.S. and Canadian cannabis stocks briefly tumbled after the U.S. attorney general’s blockbuster decision last week to rescind Obama-era protections for the legal cannabis industry. But by Friday’s close, the day after Sessions dropped his bombshell, U.S. marijuana stocks had recouped about […]

Read More

Canopy adds 1.7 million square feet of marijuana greenhouse space in B.C.

Canopy Growth plans to exercise an option to develop an additional 1.7-million-square-foot greenhouse in British Columbia, bringing its production space in the province to 3 million square feet once the facilities are fully licensed. In October, Canopy announced plans to form a joint venture with a greenhouse operator to develop a 1.3-million-square-foot greenhouse in B.C., […]

Read More

Aurora inks deal to build ‘Europe’s largest’ cannabis facility in Denmark

A Canadian medical marijuana grower is partnering with a major European greenhouse operator to create “Europe’s largest” medical cannabis producer in Denmark, becoming the second licensed cultivator to build a facility in the Scandinavian country. Alberta-based Aurora Cannabis and Alfred Pedersen & Son (APS) plan to form a joint venture called Aurora Nordic Cannabis A/S […]

Read More

Canada’s Emerald Health Therapeutics inks pact to raise CA$15 million

Emerald Health Therapeutics signed a deal to raise 15 million Canadian dollars ($12 million) – funds the British Columbia-based licensed producer plans to put toward production and growth plans. Under the agreement, a single Canadian institutional accredited investor agreed to purchase 3 million shares of the publicly traded company for CA$5 each. The deal is […]

Read More